title: Platelet activation determines angiopoietin-1 and VEGF levels in malaria: implications for their use as biomarkers.
abstract: BACKGROUND
  The angiogenic proteins angiopoietin (Ang)-1, Ang-2 and vascular endothelial growth factor (VEGF) are regulators of endothelial inflammation and integrity. Since platelets store large amounts of Ang-1 and VEGF, measurement of circulation levels of these proteins is sensitive to platelet number, in vivo platelet activation and inadvertent platelet activation during blood processing. We studied plasma Ang-1, Ang-2 and VEGF levels in malaria patients, taking the necessary precautions to avoid ex vivo platelet activation, and related plasma levels to platelet count and the soluble platelet activation markers P-selectin and CXCL7.
  
  
  METHODS
  Plasma levels of Ang-1, Ang-2, VEGF, P-selectin and CXCL7 were measured in CTAD plasma, minimizing ex vivo platelet activation, in 27 patients with febrile Plasmodium falciparum malaria at presentation and day 2 and 5 of treatment and in 25 healthy controls.
  
  
  RESULTS
  Levels of Ang-1, Ang-2 and VEGF were higher at day 0 in malaria patients compared to healthy controls. Ang-2 levels, which is a marker of endothelial activation, decreased after start of antimalarial treatment. In contrast, Ang-1 and VEGF plasma levels increased and this corresponded with the increase in platelet number. Soluble P-selectin and CXCL7 levels followed the same trend as Ang-1 and VEGF levels. Plasma levels of these four proteins correlated strongly in malaria patients, but only moderately in controls.
  
  
  CONCLUSIONS
  In contrast to previous studies, we found elevated plasma levels of Ang-1 and VEGF in patients with malaria resulting from in vivo platelet activation. Ang-1 release from platelets may be important to dampen the disturbing effects of Ang-2 on the endothelium. Evaluation of plasma levels of these angiogenic proteins requires close adherence to a stringent protocol to minimize ex vivo platelet activation.
authors.affiliation: Department of Clinical Chemistry and Haematology, University Medical Centre, Utrecht, The Netherlands.
authors.forename: Judith
authors.initials: J
authors.lastname: Brouwers
authors.forename: Rintis
authors.initials: R
authors.lastname: Noviyanti
authors.forename: Rob
authors.initials: R
authors.lastname: Fijnheer
authors.forename: Philip G
authors.initials: PG
authors.lastname: de Groot
authors.forename: Leily
authors.initials: L
authors.lastname: Trianty
authors.forename: Siti
authors.initials: S
authors.lastname: Mudaliana
authors.forename: Mark
authors.initials: M
authors.lastname: Roest
authors.forename: Din
authors.initials: D
authors.lastname: Syafruddin
authors.forename: Andre
authors.initials: A
authors.lastname: van der Ven
authors.forename: Quirijn
authors.initials: Q
authors.lastname: de Mast
mesh_terms: D000293:Adolescent; D000328:Adult; D042683:Angiopoietin-1 / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D002648:Child; D005260:Female; D006801:Humans; D008288:Malaria / Q000097:blood*; D008297:Male; D015539:Platelet Activation; D010976:Platelet Count; D018709:Statistics, Nonparametric; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*; D055815:Young Adult
chemical_list: C467630:ANGPT1 protein, human; D042683:Angiopoietin-1; D015415:Biomarkers; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A